Flow‐induced hemolysis is a crucial issue for many biomedical applications; in particular, it
is an essential issue for the development of blood‐transporting devices such as left …

Mechanically assisted circulation (MAC) sustains the blood circulation in the body of a
patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) or on ventricular …

Ventricular assist devices (VADs), among which the HeartMate 3 (HM3) is the latest clinically
approved representative, are often the therapy of choice for patients with end‐stage heart …

Purpose Device-induced blood damage contributes the hemolysis, thrombosis and bleeding
complications in patients supported with ventricular assist device (VAD). This study aims to …

Patients with ventricular assist devices still suffer from high rates of adverse events. Since
many of these complications are linked to the flow field within the pump, optimization of the …

The evolution of complex flow structures has a large impact on the hemocompatibility of the
centrifugal blood pump. In this study, the hemodynamic performance and the …

Purpose The design and optimization of centrifugal blood pumps are crucial for improved
extracorporeal membrane oxygenation system performance. Secondary flow passages are …

Left ventricular assist devices are routinely used to treat patients with advanced heart failure
as a bridge to transplant or a destination therapy. However, non-physiological shear stress …

In this study, the flow features and device‐associated blood trauma in 4 clinical ventricular
assist devices (VADs; 2 implantable axial VADs, 1 implantable centrifugal VAD, and 1 …

Mechanical circulatory support using ventricular assist devices is a common technique for
treating patients suffering from advanced heart failure. The latest generation of devices is …